Advertisement
Canada markets closed

  • S&P/TSX

    22,308.93
    -66.90 (-0.30%)
     

  • S&P 500

    5,222.68
    +8.60 (+0.16%)
     

  • DOW

    39,512.84
    +125.08 (+0.32%)
     

  • CAD/USD

    0.7317
    +0.0006 (+0.08%)
     

  • CRUDE OIL

    78.20
    -1.06 (-1.34%)
     

  • Bitcoin CAD

    83,320.70
    -2,774.25 (-3.22%)
     

  • CMC Crypto 200

    1,260.72
    -97.29 (-6.95%)
     

  • GOLD FUTURES

    2,366.90
    +26.60 (+1.14%)
     

  • RUSSELL 2000

    2,059.78
    -13.85 (-0.67%)
     

  • 10-Yr Bond

    4.5040
    +0.0550 (+1.24%)
     

  • NASDAQ

    16,340.87
    -5.40 (-0.03%)
     

  • VOLATILITY

    12.55
    -0.14 (-1.10%)
     

  • FTSE

    8,433.76
    +52.41 (+0.63%)
     

  • NIKKEI 225

    38,229.11
    +155.13 (+0.41%)
     

  • CAD/EUR

    0.6789
    +0.0011 (+0.16%)
     
MARKETS LIVE BLOG:

STOCKS CLIMB AS DOW POSTS 8TH STRAIGHT WIN

Fed's Michelle Bowman echoes higher-for-longer mantra for interest rates

NeuroOne Medical Technologies Corporation Presenting at the Benzinga Biotech Small Cap Conference

Newsfile Corp.
·1 min read

Detroit, Michigan--(Newsfile Corp. - March 18, 2021) - NeuroOne Medical Technologies Corporation (OTCQB:NMTC) will be presenting at the Benzinga Biotech Small Cap Conference taking place on March 24-25, 2021. We invite our shareholders and all interested parties to explore biotech small cap investment opportunities through two days of networking, deal-making and discovery.

About the Benzinga Biotech Small Cap Conference

The Benzinga Biotech Small Cap Conference bridges the gap between biotech companies, investors, and traders. Discover the companies in the biotech space who are helping to bring the world back to normalcy in the wake of the COVID-19 pandemic.

ADVERTISEMENT

For more information on the conference please visit: https://www.benzinga.com/events/small-cap/biotech/.

We look forward to seeing you there.

For further information:

NeuroOne Medical Technologies Corporation
Dave Rosa
daver@n1mtc.com
www.n1mtc.com

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/77609